Mass Spectrometry – News and Features

News
Scientists Find new way to Search for Origin of Life
Researchers has developed protocols and procedures for adapting DNA microarray technology to identify molecule/mineral pairs.

News
Waters and Advion BioSciences Announce Collaboration
Companies to integrate the Advion TriVersa NanoMate chip-based infusion technology with the Waters® Synapt High Definition MS™ System

News
Research and Markets Announces the Addition of Proteomics: Current State and Future Directions
Research delivers an up-to-the-minute assessment of the state of proteomics and its applications in drug and biomarker discovery.

News
Thermo and RITT Program Announce Collaborative R&D Agreement
The RITT Industrial BioDevelopment Laboratory has been equipped with over $1,000,000 (Canadian) of Thermo laboratory equipment.

News
Fueled by Major Grant, Scientists to Identify Protein Markers for Cancer
The grants signal the NCI’s strategic shift toward studies aimed at early detection of cancer.

News
GenoLogics Targets Translational Medicine, Cancer Research with Partnership Strategy of End-to-End Solutions
GenoLogics kicks off the partnership initiative by demonstrating fully integrated translational research and cancer research solutions.

News
Cenix, Applied Biosystems and Dresden University Announce Collaboration
Collaboration to create facility for proteomics profiling of RNAi and drug effects in human cells.

News
Cerno Bioscience Signs Agreements with Leading Pharmaceutical Research Programs in Shanghai
Cerno Bioscience announces two major agreements have been reached with leading research institutes in China for the use of its MS data analysis software, MassWorks™.

News
Using MALDI-TOF to Characterize new Biomarkers that Predict for Down's Syndrome
A heavily glycosylated fragment of hCG has been shown to be produced by malignant tumors and has been observed during abnormal pregnancies, such as Down's syndrome.

News
Accium BioSciences and CMIC Announce Strategic Alliance
Accium and CMIC Co. to offer Exploratory-IND (microdosing) and low-radiation PK/ADME clinical trials services to Japan pharmaceutical clients.
Advertisement